Drugs that treat depression and schizophrenia might not be triggering the most appropriate response in brain cells, new research suggests. This study examined the early chemical events that happen when a particular serotonin receptor on brain cells is stimulated by serotonin and by a hallucinogenic agent thought to mimic serotonin. The findings show that although both compounds activate this receptor, they trigger different chemical pathways inside the cell.